Vor Biopharma (VOR) has transformed into a late-stage autoimmune drug developer, focusing on telitacicept, a dual BAFF/APRIL ...

The Institute for Applied Health Intelligence would explore transition from promising trials to full implementation.

A noninvasive blood-based test identified cases of endometriosis that were missed by imaging, data at the Endocrine Society ...

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project ...